Displaying all 2 publications

Abstract:
Sort:
  1. Bin Said LN, Chyi LS, Anak Talin BA, Foo Khiong AL, Mohamad Rosli IAB, Pei Sze JL, et al.
    Curr Drug Saf, 2023 Mar 03.
    PMID: 36872362 DOI: 10.2174/1574886318666230303141522
    BACKGROUND: The labelling of dispensed medicines (LDM) ensures that optimum therapy is achieved, and medication errors are prevented. In Malaysia, LDM is enforced under Poisons Act 1952.

    OBJECTIVE: To explore the knowledge, perception, and practices of community pharmacists (CP) and general practitioners (GP) on LDM.

    METHODS: A cross-sectional study was conducted from April 2019 until March 2020 among CP and GP practising in Sarawak, Malaysia. Sample sizes were 90 and 150 for CP and GP, respectively. A self-administered structured questionnaire which was pre-tested and pilot-tested was employed to explore the knowledge and perception. Practices were assessed by having participants prepare dispensed medicine labels (DML) using simulated patients and prescriptions.

    RESULTS: 250 participants; 96 CP and 154 GP participated. While most of them perceived that they know the requirements of LDM (n=244; 97.6%), their median knowledge score was poor (57.1%). The median knowledge score of CP (66.7%) was significantly higher (P=0.004) than GP (50.0%). The majority of participants perceived that LDM is important (n= 237; 94.8%) and necessary (n=239; 95.6%%) and perceived that poor compliance to the requirements would lead to medication errors (n=243; 97.2%). Although their knowledge was poor, their median practice score (100.0%) was excellent. There was no correlation between knowledge and perception with the practice on LDM.

    CONCLUSION: The majority of CP and GP perceived that LDM is important. Interestingly, although their knowledge of the requirements of LDM was poor, their practices were good. (236 words).

  2. Ting CY, Ahmad Zaidi Adruce S, Lim CJ, Abd Jabar AHA, Ting RS, Ting H, et al.
    Res Social Adm Pharm, 2021 02;17(2):344-355.
    PMID: 32327398 DOI: 10.1016/j.sapharm.2020.03.026
    BACKGROUND: A pharmacist-led structured group-based intervention (MEDIHEALTH) was formulated to improve medication adherence among Malay type 2 diabetes mellitus (T2DM) patients in the Malaysian state of Sarawak.

    OBJECTIVES: The objective of this study was to examine the effectiveness of MEDIHEALTH and its mechanism of impact for improving medication adherence and the glycated haemoglobin (HbA1c) level.

    METHODS: A two group and parallel randomised controlled trial with a twelve months follow-up period was conducted at two primary health clinics in Malaysia that were surrounded by Malay communities. Malay T2DM patients whose HbA1c was >7% and total score on the Self-Efficacy for Appropriate Medication Use Scale (SEAMS) was <26 were recruited and parallelly randomised to the MEDIHEALTH or usual care (control) groups. The extended theory of planned behaviour was employed to test the mechanism of impact. Repeated measure analysis of variance was used to assess the difference in the estimated marginal mean of the SEAMS scores and HbA1c level between the intervention and control groups at different times.

    RESULTS: A total of 142 participants were recruited and randomised; three from the intervention group and eight from the control group withdrew before receiving any treatment. Hence, 68 participants in the intervention group and 63 in the control group were included for analyses. The MEDIHEALTH group had a significantly greater increase in the SEAMS score compared to the control group (p 
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links